| Literature DB >> 32610601 |
Vanessa Acebes-Fernández1, Alicia Landeria-Viñuela1, Pablo Juanes-Velasco1, Angela-Patricia Hernández1, Andrea Otazo-Perez1, Raúl Manzano-Román2, Rafael Gongora1, Manuel Fuentes1,2.
Abstract
The broad relationship between the immune system and cancer is opening a new hallmark to explore for nanomedicine. Here, all the common and synergy points between both areas are reviewed and described, and the recent approaches which show the progress from the bench to the beside to biomarkers developed in nanomedicine and onco-immunotherapy.Entities:
Keywords: immune response; immune-checkpoint inhibitors; immunogenic cell death; immunotherapy; nano-conjugates; nano-vaccines; nanomaterials; nanomedicine; oncotherapy
Year: 2020 PMID: 32610601 PMCID: PMC7407304 DOI: 10.3390/nano10071274
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076